Table 2 Characteristics of included observational studies
Author, year population (number) | Echocardiography timing | GLS software and TTE views used | Data reported | SAPS SOFA APACHE | MV | Mortality | Longest follow up |
|---|---|---|---|---|---|---|---|
Boissier, 2017 78 ICU patients with septic shock | TTE within 24 h of ICU admission | Philips’ Qlab 8.1 (Philips®) Ap: 4ch, 2ch | GLS and LVEF | 60.1 ± 20.5 11.7 ± 3.4 - | 84.6% | 43.6% | Hospital |
Chang, 2015 111 ICU patients with septic shock | TTE within 24 h of ICU admission | EchoPAC v. BT09 (GE®) Ap: 4ch, 2ch, 3ch | GLS and LVEF | - - 21 ± 8 | 65.8% | 35.1% | Hospital |
De Geer, 2014 50 ICU patients with septic shock | TTE within 24 h of ICU admission | EchoPac v. 112 (GE®) Ap: 4ch, 2ch, 3ch | GLS and LVEF | - 11 (9–12) - | 84% | 34% | 90-day |
Innocenti, 2016 56 ED patients with septic shock | TTE within 24 h if ICU admission | Philips’ Qlab 8.1 (Philips®) Ap: 4ch, 2ch | GLS and LVEF | - 6.3 ± 2.8 - | – | 27.2% | 28-day |
Landesberg, 2014 106 ICU patients with severe sepsis or septic shock | TTE on ICU admission day or as soon as possible | Philips’ Qlab 8.1 (Philips®) Ap: 4ch, 2ch | GLS and LVEF | - - 21.61 ± 6.8 | 100% | 39% | Hospital |
Lanspa, 2017 298 ICU patients with severe sepsis or septic shock | TTE within 24 h of ICU admission | Image-Arena platform (TomTec®) Ap: 4ch | GLS | - 9 (6–12) 25 (18–23) | – | 23% | 28-day |
Orde, 2014 60 adult patients with severe sepsis or septic shock | TTE within 24 h of meeting severe sepsis criteria | Syngo Velocity Vector Imaging (Siemens®) Ap: 4ch, 2ch, 3ch | GLS and LVEF | - 11 ± 4 - | 65% | 48% | 180-day |
Shahul, 2015* 35 ICU patients with sepsis and septic shock | TTE on admission and at 24 h post | cardiac perf. Analysis v1.1 (TomTec®) Ap: 4ch | GLS and LVEF | - 6 (2.1–9) 21.7 ± 6.2 | 69% | 23.3% | 30-day |